Drug Search Results
More Filters [+]

Pranoprofen

Alternative Names: pranoprofen
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | Germany | Italy | Jordan | Korea | Mexico | Morocco | Poland | Portugal | Turkey

Approved Indications: None

Known Adverse Events: None

Company: Università degli Studi di Brescia
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pranoprofen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Macular Edema

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2300073199

N/A

Not yet recruiting

Keratoconjunctivitis Sicca

2023-08-30

ChiCTR2100047726

N/A

Completed

Pterygium

2020-12-31

ChiCTR1900021312

N/A

Recruiting

Cataract

2019-01-31

OHSV

N/A

Unknown status

Herpes Simplex|Keratitis, Herpetic

2018-03-01

Recent News Events